These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32482717)

  • 1. Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings.
    Norum KR; Remaley AT; Miettinen HE; Strøm EH; Balbo BEP; Sampaio CATL; Wiig I; Kuivenhoven JA; Calabresi L; Tesmer JJ; Zhou M; Ng DS; Skeie B; Karathanasis SK; Manthei KA; Retterstøl K
    J Lipid Res; 2020 Aug; 61(8):1142-1149. PubMed ID: 32482717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LCAT- targeted therapies: Progress, failures and future.
    Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
    Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.
    Freeman LA; Karathanasis SK; Remaley AT
    Curr Opin Lipidol; 2020 Apr; 31(2):71-79. PubMed ID: 32073411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
    Vaisman BL; Neufeld EB; Freeman LA; Gordon SM; Sampson ML; Pryor M; Hillman E; Axley MJ; Karathanasis SK; Remaley AT
    J Pharmacol Exp Ther; 2019 Mar; 368(3):423-434. PubMed ID: 30563940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
    Ng DS
    Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
    Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
    Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
    Kuroda M; Holleboom AG; Stroes ES; Asada S; Aoyagi Y; Kamata K; Yamashita S; Ishibashi S; Saito Y; Bujo H
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1756-62. PubMed ID: 24876348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
    Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
    PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.
    Freeman LA; Demosky SJ; Konaklieva M; Kuskovsky R; Aponte A; Ossoli AF; Gordon SM; Koby RF; Manthei KA; Shen M; Vaisman BL; Shamburek RD; Jadhav A; Calabresi L; Gucek M; Tesmer JJG; Levine RL; Remaley AT
    J Pharmacol Exp Ther; 2017 Aug; 362(2):306-318. PubMed ID: 28576974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.
    Freeman LA; Shamburek RD; Sampson ML; Neufeld EB; Sato M; Karathanasis SK; Remaley AT
    J Lipid Res; 2019 May; 60(5):1050-1057. PubMed ID: 30808683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator Compound.
    Pavanello C; Ossoli A; Turri M; Strazzella A; Simonelli S; Laurenzi T; Kono K; Yamada K; Kiyosawa N; Eberini I; Calabresi L
    J Pharmacol Exp Ther; 2020 Dec; 375(3):463-468. PubMed ID: 32980814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.
    Amar MJA; Freeman LA; Nishida T; Sampson ML; Pryor M; Vaisman BL; Neufeld EB; Karathanasis SK; Remaley AT
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00554. PubMed ID: 31893124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.
    Mehta R; Elías-López D; Martagón AJ; Pérez-Méndez OA; Sánchez MLO; Segura Y; Tusié MT; Aguilar-Salinas CA
    Lipids Health Dis; 2021 Jul; 20(1):70. PubMed ID: 34256778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.